KK Hitachi Seisakusho header image

KK Hitachi Seisakusho

6501

Equity

ISIN JP3788600009 / Valor 761899

Tokyo Stock Exchange (2024-10-24)
JPY 3,974.00+2.00%

KK Hitachi Seisakusho
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

KK Hitachi Seisakusho, commonly known as Hitachi, Ltd., is a diversified multinational conglomerate headquartered in Tokyo, Japan. The company operates across various sectors, including Information & Telecommunication Systems, Social Infrastructure, High Functional Materials & Components, Financial Services, Power Systems, Electronic Systems & Equipment, and Automotive Systems. Hitachi's business model focuses on leveraging its extensive portfolio of products, from electronics to industrial machinery, and integrating these with digital technologies to provide innovative solutions. The company aims to address complex challenges in society by offering reliable products and services that are enhanced through digital connectivity. While Hitachi emphasizes its commitment to creating sustainable value, its core business strategy revolves around the development, manufacturing, and sale of a wide range of products and services designed to meet the evolving needs of its global customer base.

Summarized from source with an LLMView SourceSector: Technology

Latest Results (07.08.2024):

Revenue Decline

KK Hitachi Seisakusho reported consolidated revenues of 9,728.7 billion yen for the fiscal year ending March 31, 2024, marking an 11% decrease compared to the previous fiscal year. This decline was primarily attributed to the transition of Hitachi Astemo to an equity method affiliate.

Adjusted Operating Income

For the fiscal year ending March 31, 2024, KK Hitachi Seisakusho's adjusted operating income increased by 7.6 billion yen year over year, reaching 755.8 billion yen. This growth was driven by robust performance in the Digital Systems & Services, Green Energy & Mobility, and Connective Industries sectors.

Net Income Decrease

KK Hitachi Seisakusho's net income for the fiscal year ending March 31, 2024, decreased by 77.1 billion yen year over year, totaling 626.7 billion yen. The decline was mainly due to an increase in income tax expenses.

Cash Flows from Operating Activities

During the fiscal year ending March 31, 2024, KK Hitachi Seisakusho generated net cash of 956.6 billion yen from operating activities, an increase of 129.5 billion yen compared to the previous fiscal year. This improvement was largely due to better working capital management and net gains from business reorganizations.

Outlook for Fiscal 2024

KK Hitachi Seisakusho forecasts revenues of 9,000.0 billion yen for the fiscal year ending March 31, 2025, representing a 7% year-over-year decrease. However, the company expects adjusted operating income to rise to 855.0 billion yen, reflecting a 99.1 billion yen increase, driven by continued global expansion and business structural reforms.

Summarized from source with an LLMView Source

Key figures

125%1Y
197%3Y
373%5Y

Performance

44.2%1Y
34.2%3Y
34.6%5Y

Volatility

Market cap

122295 M

Market cap (USD)

Daily traded volume (Shares)

16,089,400

Daily traded volume (Shares)

1 day high/low

4012 / 3821

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

Intellia Therapeutics Inc
Intellia Therapeutics Inc Intellia Therapeutics Inc Valor: 32256913
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.63%USD 15.95
Array Technologies Inc
Array Technologies Inc Array Technologies Inc Valor: 57373259
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
4.38%USD 6.44
MaxLinear Inc
MaxLinear Inc MaxLinear Inc Valor: 11132674
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.59%USD 14.85
Beam Therapeutics Inc
Beam Therapeutics Inc Beam Therapeutics Inc Valor: 50337226
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.44%USD 21.55
Prothena Corporation PLC
Prothena Corporation PLC Prothena Corporation PLC Valor: 20224443
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-5.96%USD 15.30
Immunocore Holdings PLC
Immunocore Holdings PLC Immunocore Holdings PLC Valor: 59524572
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.92%USD 32.80
JOYY Inc
JOYY Inc JOYY Inc Valor: 51728275
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.98%USD 34.12
Relay Therapeutics Inc
Relay Therapeutics Inc Relay Therapeutics Inc Valor: 55675918
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.75%USD 6.02
Tandem Diabetes Care Inc
Tandem Diabetes Care Inc Tandem Diabetes Care Inc Valor: 38586336
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.29%USD 31.35
Sonos Inc
Sonos Inc Sonos Inc Valor: 37722921
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.63%USD 12.78